FOXO1 involvement in insulin resistance-related pro-inflammatory cytokine production in hepatocytes (Q39416732)

11 September 2017

FOXO1 involvement in insulin resistance-related pro-inflammatory cytokine production in hepatocytes (English)

1 reference

11 September 2017

1 reference

Hongming Miao

1

1 reference

11 September 2017

Yang Zhang

2

1 reference

11 September 2017

Zhongyan Lu

3

1 reference

11 September 2017

Qin Liu

4

1 reference

11 September 2017

Lixia Gan

5

1 reference

11 September 2017

6 January 2012

1 reference

11 September 2017

Inflammation Research

1 reference

11 September 2017

61

1 reference

11 September 2017

4

1 reference

11 September 2017

349-358

1 reference

https://scigraph.springernature.com/pub.10.1007/s00011-011-0417-3

11 September 2017

0 references

cites work

Inflammation and insulin resistance

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

Inflammatory mechanisms in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

Insulin resistance, inflammation, and non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

Fenofibrate reduces fasting and postprandial inflammatory responses among hypertriglyceridemia patients with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

A stress signaling pathway in adipose tissue regulates hepatic insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

CCR2 modulates inflammatory and metabolic effects of high-fat feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

Non-genomic action of TCDD to induce inflammatory responses in HepG2 human hepatoma cells and in liver of C57BL/6J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

Berberine inhibits inflammatory response and ameliorates insulin resistance in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

Regulation of the forkhead transcription factor FKHR, but not the PAX3-FKHR fusion protein, by the serine/threonine kinase Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

A combination of genomic approaches reveals the role of FOXO1a in regulating an oxidative stress response pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

Down-regulation of FoxO-dependent c-FLIP expression mediates TRAIL-induced apoptosis in activated hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

Foxo1 integrates insulin signaling with mitochondrial function in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

Targeting Forkhead box O1 from the concept to metabolic diseases: lessons from mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

Foxo1 mediates insulin action on apoC-III and triglyceride metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

FoxO1 links insulin resistance to proinflammatory cytokine IL-1beta production in macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

Foxo1 increases pro-inflammatory gene expression by inducing C/EBPbeta in TNF-alpha-treated adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

Does central obesity reflect "Cushing's disease of the omentum"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

MRNA and enzyme activity of hepatic 11beta-hydroxysteroid dehydrogenase type 1 are elevated in C57BL/KsJ-db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

Vitamin A decreases pre-receptor amplification of glucocorticoids in obesity: study on the effect of vitamin A on 11beta-hydroxysteroid dehydrogenase type 1 activity in liver and visceral fat of WNIN/Ob obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

Reactive oxygen species have a causal role in multiple forms of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

Anti-inflammatory effect of insulin in the human hepatoma cell line HepG2 involves decreased transcription of IL-6 target genes and nuclear exclusion of FOXO1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

FoxO1 regulates Tlr4 inflammatory pathway signalling in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

SIRT1 regulates adiponectin gene expression through Foxo1-C/enhancer-binding protein alpha transcriptional complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

Akt modulates STAT3-mediated gene expression through a FKHR (FOXO1a)-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

PPAR{alpha} mediates the hypolipidemic action of fibrates by antagonizing FoxO1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

Decreased lipid synthesis in livers of mice with disrupted Site-1 protease gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

FOXO1 functions as a master switch that regulates gene expression necessary for tumor necrosis factor-induced fibroblast apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-011-0417-3

Regulation of phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein-1 gene expression by insulin. The role of winged helix/forkhead proteins

21 January 2018

1 reference

12 December 2020

FKHR Binds the Insulin Response Element in the Insulin-Like Growth Factor Binding Protein-1 Promoter1

1 reference

12 December 2020

FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice

1 reference

12 December 2020

Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity.

1 reference

12 December 2020

Hepatocyte nuclear factor-4 is a novel downstream target of insulin via FKHR as a signal-regulated transcriptional inhibitor

1 reference

12 December 2020

Inflammatory cytokines modulate chemokine production patterns of HepG2 cells toward initially inclined direction

1 reference

12 December 2020

Amelioration of high-fat feeding-induced insulin resistance in skeletal muscle with the antiglucocorticoid RU486.

1 reference

12 December 2020

10.1007/S00011-011-0417-3

Identifiers

DOI

1 reference

11 September 2017

1 reference